ST3GAL1 and neoplasm: In contrast, βII-spectrin, a cytoskeletal molecule expressed on CAR-T cells, enhances the tumour specificity of CAR-T cells to localize to the tumour site and is able to reverse ST3GAL1-mediated non-specific T-cell migration, thereby inhibiting tumour growth in mice (6).